QVIDTVM Management LLC Has $12.42 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

QVIDTVM Management LLC lifted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 75.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 458,866 shares of the medical instruments supplier’s stock after purchasing an additional 197,803 shares during the period. DENTSPLY SIRONA accounts for 8.7% of QVIDTVM Management LLC’s holdings, making the stock its 5th biggest position. QVIDTVM Management LLC’s holdings in DENTSPLY SIRONA were worth $12,417,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently made changes to their positions in the stock. UMB Bank n.a. grew its holdings in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 753 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of DENTSPLY SIRONA in the third quarter valued at approximately $27,000. LRI Investments LLC lifted its position in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after buying an additional 564 shares during the last quarter. Rothschild Investment LLC bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter worth approximately $32,000. Finally, Kennebec Savings Bank acquired a new position in shares of DENTSPLY SIRONA during the 3rd quarter worth approximately $35,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Needham & Company LLC decreased their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research note on Friday, October 25th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Barrington Research lowered their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Seven equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Up 4.0 %

Shares of XRAY stock opened at $19.52 on Tuesday. DENTSPLY SIRONA Inc. has a 1 year low of $17.21 and a 1 year high of $37.60. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a 50 day simple moving average of $23.25 and a 200 day simple moving average of $25.05.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company’s revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company posted $0.49 EPS. Equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.